These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38585537)

  • 21. The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients.
    Filgueira TO; Carvalho PRC; de Sousa Fernandes MS; Castoldi A; Teixeira AM; de Albuquerque RB; de Lima-Filho JL; Souto FO
    Front Immunol; 2022; 13():1051059. PubMed ID: 36685603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients.
    Mansoor S; Butt AR; Bibi A; Mushtaq S; Ullah I; Alshahrani F; Khan A; Mansoor A
    PLoS One; 2023; 18(9):e0291332. PubMed ID: 37756264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study.
    Tufa A; Gebremariam TH; Manyazewal T; Getinet T; Webb DL; Hellström PM; Genet S
    Front Immunol; 2022; 13():964179. PubMed ID: 35958594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low molecular weight cytotoxic components (DAMPs) form the post-COVID-19 syndrome.
    Klimova EM; Bozhkov AI; Lavinska OV; Drozdova LA; Kurhuzova NI
    Immunobiology; 2023 Jan; 228(1):152316. PubMed ID: 36565610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
    Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
    J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients.
    Mazaheri T; Ranasinghe R; Al-Hasani W; Luxton J; Kearney J; Manning A; Dimitriadis GK; Mare T; Vincent RP
    PLoS One; 2022; 17(5):e0266652. PubMed ID: 35500008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq.
    Merza MY; Hwaiz RA; Hamad BK; Mohammad KA; Hama HA; Karim AY
    PLoS One; 2021; 16(4):e0250330. PubMed ID: 33914789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between serum inflammatory parameters and the disease severity in COVID-19 patients.
    Mardani R; Namavar M; Ghorbi E; Shoja Z; Zali F; Kaghazian H; Aghasadeghi MR; Sadeghi SA; Sabeti S; Darazam IA; Ahmadi N; Mousavi-Nasab SD
    J Clin Lab Anal; 2022 Jan; 36(1):e24162. PubMed ID: 34874079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact understanding of exosome therapy in COVID-19 and preparations for the future approaches in dealing with infectious diseases and inflammation.
    Nasiri Z; Soleimanjahi H; Baheiraei N; Hashemi SM; Pourkarim MR
    Sci Rep; 2024 Mar; 14(1):5724. PubMed ID: 38459174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological and virological aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and hepatitis C virus.
    León FJF; da Silva LL; Santos AC; Duarte da Costa V; Miguel JC; Marques JT; Nascimento GP; Ferreira da Silva E; Lewis-Ximenez LL; Villar LM; de Paula VS
    J Med Virol; 2022 May; 94(5):2296-2301. PubMed ID: 35064576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological map in COVID-19.
    Li CH; Chiou HC; Lin MH; Kuo CH; Lin YC; Lin YC; Hung CH; Kuo CH
    J Microbiol Immunol Infect; 2021 Aug; 54(4):547-556. PubMed ID: 34023234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of serum cytokines in patients with severe acute respiratory syndrome.
    Zhang Y; Li J; Zhan Y; Wu L; Yu X; Zhang W; Ye L; Xu S; Sun R; Wang Y; Lou J
    Infect Immun; 2004 Aug; 72(8):4410-5. PubMed ID: 15271897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.
    Zhao Y; Qin L; Zhang P; Li K; Liang L; Sun J; Xu B; Dai Y; Li X; Zhang C; Peng Y; Feng Y; Li A; Hu Z; Xiang H; Ogg G; Ho LP; McMichael A; Jin R; Knight JC; Dong T; Zhang Y
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32501293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
    Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
    Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Specific Pattern and Dynamics of Circulating Cytokines Are Associated with the Extension of Lung Injury and Mortality in Colombian Adults with Coronavirus Disease-19.
    Bolívar-Marín S; Castro M; Losada-Floriano D; Cortés S; Perdomo-Celis F; Lastra G; Narváez CF
    J Interferon Cytokine Res; 2023 May; 43(5):206-215. PubMed ID: 37103589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.
    Massa F; Vigo T; Bellucci M; Giunti D; Emanuela MM; Visigalli D; Capodivento G; Cerne D; Assini A; Boni S; Rizzi D; Narciso E; Grisanti GS; Coco E; Uccelli A; Schenone A; Franciotta D; Benedetti L
    Neurol Sci; 2024 Mar; 45(3):849-859. PubMed ID: 38169013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.